rRp450

N/A

Report date: 2023/01/07 18:44:56

Base Information

Drug NamerRp450

Drug Alias NamerRp450NSC-715818

ClassificationBiologics > Oncolytic virus

Mechanisms of ActionCell death stimulants

TargetsNot applicable

Therapy Area/IndicationsLiver Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesNational Cancer Institute Harvard Medical School

China Registration ClassN/A

Develop Information

Active CompaniesNational Cancer Institute Harvard Medical School

Inactive CompaniesN/A

Active IndicationsLiver Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A

Related LinksN/A